doi: 10.1161/01.STR.0000014421.15948.67
(Stroke. 2002;33:1152.)
© 2002 American Heart Association, Inc.
Comments, Opinions, and Reviews |
Alzheimer Disease as a Vascular Disorder
Nosological Evidence
From the Department of Neuropathology, University of California at San Diego.
Correspondence to J.C. de la Torre, MD, PhD, Department of Pathology, University of California at San Diego, 1363 Shinly, Suite 100, Escondido, CA 92026. E-mail jdelator{at}nctimes.net
Background— The main stumbling block in the clinical management and in the search for a cure of Alzheimer disease (AD) is that the cause of this disorder has remained uncertain until now.
Summary of Review— Evidence that sporadic (nongenetic) AD is primarily a vascular rather than a neurodegenerative disorder is reviewed. This conclusion is based on the following evidence: (1) epidemiological studies showing that practically all risk factors for AD reported thus far have a vascular component that reduces cerebral perfusion; (2) risk factor association between AD and vascular dementia (VaD); (3) improvement of cerebral perfusion obtained from most pharmacotherapy used to reduce the symptoms or progression of AD; (4) detection of regional cerebral hypoperfusion with the use of neuroimaging techniques to preclinically identify AD candidates; (5) presence of regional brain microvascular abnormalities before cognitive and neurodegenerative changes; (6) common overlap of clinical AD and VaD cognitive symptoms; (7) similarity of cerebrovascular lesions present in most AD and VaD patients; (8) presence of cerebral hypoperfusion preceding hypometabolism, cognitive decline, and neurodegeneration in AD; and (9) confirmation of the heterogeneous and multifactorial nature of AD, likely resulting from the diverse presence of vascular risk factors or indicators of vascular disease.
Conclusions— Since the value of scientific evidence generally revolves around probability and chance, it is concluded that the data presented here pose a powerful argument in support of the proposal that AD should be classified as a vascular disorder. According to elementary statistics, the probability or chance that all these findings are due to an indirect pathological effect or to coincidental circumstances related to the disease process of AD seems highly unlikely. The collective data presented in this review strongly support the concept that sporadic AD is a vascular disorder. It is recommended that current clinical management of patients, treatment targets, research designs, and disease prevention efforts need to be critically reassessed and placed in perspective in light of these important findings.
Key Words: Alzheimer disease • dementia • microcirculation • risk factors • vascular disorders
This article has been cited by other articles:
 |
|
 |
|
  C. M. Holland, E. E. Smith, I. Csapo, M. E. Gurol, D. A. Brylka, R. J. Killiany, D. Blacker, M. S. Albert, C. R.G. Guttmann, and S. M. Greenberg Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging Stroke, April 1, 2008; 39(4): 1127 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Libon, C. C. Price, T. Giovannetti, R. Swenson, B. M. Bettcher, K. M. Heilman, and A. Pennisi Linking MRI Hyperintensities With Patterns of Neuropsychological Impairment: Evidence for a Threshold Effect Stroke, March 1, 2008; 39(3): 806 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Merino Untangling Vascular Cognitive Impairment Stroke, March 1, 2008; 39(3): 739 - 740. [Full Text] [PDF]
|
|
|
|
 |
|
 S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Massoud Maladie d'Alzheimer Can Fam Physician, January 1, 2007; 53(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Stenset, L. Johnsen, D. Kocot, A. Negaard, A. Skinningsrud, P. Gulbrandsen, A. Wallin, and T. Fladby Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42. Neurology, September 12, 2006; 67(5): 830 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Calderon-Margalit, B. Adler, J. H. Abramson, J. Gofin, and J. D. Kark Butyrylcholinesterase Activity, Cardiovascular Risk Factors, and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem Clin. Chem., May 1, 2006; 52(5): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Silvestrini, P. Pasqualetti, R. Baruffaldi, M. Bartolini, Y. Handouk, M. Matteis, F. Moffa, L. Provinciali, and F. Vernieri Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease Stroke, April 1, 2006; 37(4): 1010 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Peters Ageing and the brain Postgrad. Med. J., February 1, 2006; 82(964): 84 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bursi, W. A. Rocca, J. M. Killian, S. A. Weston, D. S. Knopman, S. J. Jacobsen, and V. L. Roger Heart Disease and Dementia: A Population-based Study Am. J. Epidemiol., January 15, 2006; 163(2): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Erlich, K. L. Lunetta, L. A. Cupples, M. Huyck, R. C. Green, C. T. Baldwin, L. A. Farrer, and for the MIRAGE Study Group Polymorphisms in the PON gene cluster are associated with Alzheimer disease Hum. Mol. Genet., January 1, 2006; 15(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van Oijen, J. C. Witteman, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Fibrinogen Is Associated With an Increased Risk of Alzheimer Disease and Vascular Dementia Stroke, December 1, 2005; 36(12): 2637 - 2641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Spilt, A. W. E. Weverling-Rijnsburger, H. A. M. Middelkoop, W. M. van Der Flier, J. Gussekloo, A. J. M. de Craen, E. L. E. M. Bollen, G. J. Blauw, M. A. van Buchem, and R. G. J. Westendorp Late-Onset Dementia: Structural Brain Damage and Total Cerebral Blood Flow Radiology, September 1, 2005; 236(3): 990 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Yip, A. C. McKee, R. C. Green, J. Wells, H. Young, L. A. Cupples, and L. A. Farrer APOE, vascular pathology, and the AD brain Neurology, July 26, 2005; 65(2): 259 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Beeri, J. M. Silverman, K. L. Davis, D. Marin, H. Z. Grossman, J. Schmeidler, D. P. Purohit, D. P. Perl, M. Davidson, R. C. Mohs, et al. Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 471 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Squitti, P. Pasqualetti, G. Dal Forno, F. Moffa, E. Cassetta, D. Lupoi, F. Vernieri, L. Rossi, M. Baldassini, and P. M. Rossini Excess of serum copper not related to ceruloplasmin in Alzheimer disease Neurology, March 22, 2005; 64(6): 1040 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. den Heijer, L. J. Launer, N. D. Prins, E. J. van Dijk, S. E. Vermeer, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe Neurology, January 25, 2005; 64(2): 263 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Gentile, C. Vecchione, A. Maffei, A. Aretini, G. Marino, R. Poulet, L. Capobianco, G. Selvetella, and G. Lembo Mechanisms of Soluble {beta}-Amyloid Impairment of Endothelial Function J. Biol. Chem., November 12, 2004; 279(46): 48135 - 48142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhu, M. A. Smith, G. Perry, and G. Aliev Mitochondrial failures in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, November 1, 2004; 19(6): 345 - 352. [Abstract] [PDF]
|
|
|
|
|
|
A. E. Roher, C. Esh, A. Rahman, T. A. Kokjohn, and T. G. Beach Atherosclerosis of Cerebral Arteries in Alzheimer Disease Stroke, November 1, 2004; 35(11_suppl_1): 2623 - 2627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. den Heijer, S. E Vermeer, E. J van Dijk, N. D Prins, P. J Koudstaal, C. M van Duijn, A. Hofman, and M. M. Breteler Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia Am. J. Clinical Nutrition, October 1, 2004; 80(4): 992 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Roman Age-Associated White Matter Lesions and Dementia: Are These Lesions Causal or Casual? Arch Neurol, October 1, 2004; 61(10): 1503 - 1504. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sleegers, G. Roks, J. Theuns, Y. S. Aulchenko, R. Rademakers, M. Cruts, W. A. van Gool, C. Van Broeckhoven, P. Heutink, B. A. Oostra, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population Brain, July 1, 2004; 127(7): 1641 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Altieri, V. Di Piero, M. Pasquini, M. Gasparini, N. Vanacore, E. Vicenzini, and G. L. Lenzi Delayed poststroke dementia: A 4-year follow-up study Neurology, June 22, 2004; 62(12): 2193 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Laurin, K. H. Masaki, D. J. Foley, L. R. White, and L. J. Launer Midlife Dietary Intake of Antioxidants and Risk of Late-Life Incident Dementia: The Honolulu-Asia Aging Study Am. J. Epidemiol., May 15, 2004; 159(10): 959 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rasgon and L. Jarvik Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2004; 59(2): M178 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Verghese, R. B. Lipton, C. B. Hall, G. Kuslansky, and M. J. Katz Low blood pressure and the risk of dementia in very old individuals Neurology, December 23, 2003; 61(12): 1667 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2055 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Bonelli Editorial Comment--How to Treat Vascular Dementia? Stroke, October 1, 2003; 34(10): 2331 - 2332. [Full Text] [PDF]
|
|
|
|
|
|
Z. Suo, M. Wu, B. A. Citron, R. E. Palazzo, and B. W. Festoff Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling J. Biol. Chem., September 26, 2003; 278(39): 37681 - 37689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Qiu, B. Winblad, J. Fastbom, and L. Fratiglioni Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD Neurology, September 9, 2003; 61(5): 655 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Strandberg, K. H. Pitkala, K. H. Linnavuori, and R. S. Tilvis Impact of Viral and Bacterial Burden on Cognitive Impairment in Elderly Persons With Cardiovascular Diseases Stroke, September 1, 2003; 34(9): 2126 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Qiu, B. Winblad, M. Viitanen, and L. Fratiglioni Pulse Pressure and Risk of Alzheimer Disease in Persons Aged 75 Years and Older: A Community-Based, Longitudinal Study Stroke, March 1, 2003; 34(3): 594 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Thompson, K. M. Hayashi, G. de Zubicaray, A. L. Janke, S. E. Rose, J. Semple, D. Herman, M. S. Hong, S. S. Dittmer, D. M. Doddrell, et al. Dynamics of Gray Matter Loss in Alzheimer's Disease J. Neurosci., February 1, 2003; 23(3): 994 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Qiu, E. von Strauss, J. Fastbom, B. Winblad, and L. Fratiglioni Low Blood Pressure and Risk of Dementia in the Kungsholmen Project: A 6-Year Follow-up Study Arch Neurol, February 1, 2003; 60(2): 223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. ALIEV, D. SEYIDOVA, M. L. NEAL, J. SHI, B. T. LAMB, S. L. SIEDLAK, H. V. VINTERS, E. HEAD, G. PERRY, J. C. LAMANNA, et al. Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD-Like Pathology in Aged Transgenic Mice Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 45 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. TOWNSEND, D. OBREGON, A. QUADROS, N. PATEL, Ch. VOLMAR, D. PARIS, and M. MULLAN Proinflammatory and Vasoactive Effects of A{beta} in the Cerebrovasculature Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 65 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. BUCKWALTER, J.-P. PEPPER, R. F. GAERTNER, D. V. EUW, P. LACOMBE, and T. WYSS-CORAYA Molecular and Functional Dissection of TGF-{beta}1-Induced Cerebrovascular Abnormalities in Transgenic Mice Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 87 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. KORCZYN Mixed Dementia--the Most Common Cause of Dementia Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 129 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. DE LA TORRE Vascular Basis of Alzheimer's Pathogenesis Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 196 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. PANTONI, V. PALUMBO, and C. SARTI Pathological Lesions in Vascular Dementia Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 279 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. GOLDSMITH Treatment of Alzheimer's Disease by Transposition of the Omentum Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 454 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Royall and J. C. de la Torre Alzheimer Disease as a Vascular Disorder: Nosological Evidence * Response Stroke, September 1, 2002; 33(9): 2147 - 2148. [Full Text] [PDF]
|
|